This study compared pro‐inflammatory and metabolic biomarker profiles between individuals with alcohol use disorder (AUD) and those without, and evaluated the impact of the GLP‐1 receptor agonist exenatide on these biomarkers in the AUD group. Here, GLP1R is linked to alcohol abuse.